Trials / Conditions / Myelo Dysplastic Syndrome
Myelo Dysplastic Syndrome
4 registered clinical trials studyying Myelo Dysplastic Syndrome — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST/ALT Ratio in Patients W NCT07210034 | Assiut University | — |
| Recruiting | Momelotinib in VEXAS Syndrome NCT07098936 | Groupe Francophone des Myelodysplasies | Phase 2 |
| Completed | Pharmacokinetics of Posaconazole (Noxafil®) as Prophylaxis for Invasive Fungal Infections NCT02805946 | Radboud University Medical Center | Phase 4 |
| Completed | Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients NCT02172768 | Radboud University Medical Center | Phase 2 |